| Authors: |
Hodges MR; Independent/Former Amplyx Pharmaceuticals Inc, San Diego, California, USA.; Pfizer Central Research and Development (PGRD), La Jolla, San Diego, California, USA., Tawadrous M; Clinical Development, Pfizer Inc, New York, New York, USA., Cornely OA; Faculty of Medicine, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Thompson GR; Department of Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology, UC-Davis Medical Center, Sacramento, California, USA., Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia., Maertens JA; Department of Microbiology, Immunology, and Transplantation, KULeuven, Leuven, Belgium.; Department of Hematology, UZ Leuven, Leuven, Belgium., Dadwal SS; Division of Infectious Disease, Department of Medicine, City of Hope National Medical Center Duarte, Duarte, California, USA., Rahav G; Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel., Hazel S; Clinical Operations, Independent/Former Amplyx Pharmaceuticals Inc, San Diego, California, USA.; Clinical Operations, Former Pfizer Global Research and Development, Inc, New York, New York, USA., Almas M; Department of Statistics, Global Biometrics and Data Management, Pfizer Inc, New York, New York, USA., Jakate A; Clinical Pharmacology, Pfizer Inc, New York, New York, USA., Pypstra R; Clinical Development, Pfizer Inc, New York, New York, USA. |
